1. Home
  2. AMBO vs AIDX Comparison

AMBO vs AIDX Comparison

Compare AMBO & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

N/A

Current Price

$1.84

Market Cap

5.9M

Sector

Real Estate

ML Signal

N/A

Logo 20/20 Biolabs Inc. Common Stock

AIDX

20/20 Biolabs Inc. Common Stock

BUY

Current Price

$0.37

Market Cap

4.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
AMBO
AIDX
Founded
2000
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Precision Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
4.9M
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
AMBO
AIDX
Price
$1.84
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.9K
★ 57.4K
Earning Date
11-11-2026
11-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 337.04
34.48
EPS
★ 0.00
N/A
Revenue
★ $9,469,000.00
$2,045,133.00
Revenue This Year
N/A
$44.20
Revenue Next Year
N/A
$95.73
P/E Ratio
$377.55
★ N/A
Revenue Growth
0.82
★ 16.71
52 Week Low
$1.47
$0.33
52 Week High
$5.40
$18.96

Technical Indicators

Market Signals
Indicator
AMBO
AIDX
Relative Strength Index (RSI) 35.97 34.08
Support Level $1.69 $0.33
Resistance Level $2.19 $0.49
Average True Range (ATR) 0.06 0.05
MACD -0.02 -0.00
Stochastic Oscillator 7.04 18.51

Price Performance

Historical Comparison
AMBO
AIDX

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About AIDX 20/20 Biolabs Inc. Common Stock

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

Share on Social Networks: